GPT Healthcare Limited has reported its unaudited financial results for the second quarter of FY25, showcasing steady growth in revenue along with a modest increase in profit.
Key Financial Highlights for Q2 FY25:
- Revenue from Operations: The company achieved revenue from operations amounting to ₹105.66 crore, reflecting a YoY decrease of 2.1% compared to ₹107.97 crore in Q2 FY24 but a sequential increase of 8% from ₹97.82 crore in Q1 FY25.
- Total Income: Including other income, total income stood at ₹108.47 crore, down slightly by 0.6% from ₹109.06 crore in Q2 FY24, but up 8.4% from ₹100.06 crore in Q1 FY25.
- Profit Before Tax (PBT): PBT for Q2 FY25 was ₹20.68 crore, a decline of 24.6% from ₹25.21 crore in Q2 FY24. Sequentially, PBT improved by 41.1% from ₹14.67 crore in Q1 FY25.
- Net Profit: The net profit for the period was ₹14.82 crore, marking a YoY decline of 10.5% from ₹16.52 crore in Q2 FY24, though sequentially it grew by 48.6% from ₹9.96 crore in Q1 FY25.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Neither the author nor Business Upturn is liable for any losses arising from the use of this information.
TOPICS:
GPT Healthcare